Pain Medication with an Addiction History: Planning Safer Care

An addiction history should lead to thoughtful pain care, not dismissal of pain. Treatment decisions need to address the cause and severity of pain, previous substance use, current medication, and recurrence or overdose risks. A coordinated plan can combine effective analgesia with support for ongoing recovery.

Assess pain and the current recovery situation

Pain may be acute, chronic, postoperative, or linked to another illness. The assessment should consider the cause, function, sleep, and previous treatments. Addiction history includes more than opioid use and may involve alcohol, sedatives, or other substances that affect medication choices.

Ask about current treatment, stability, previous overdose, and what has made medication use difficult in the past. These details should support individualized care rather than a punitive assumption. Severe or unexplained pain still needs appropriate medical evaluation.

Use a multimodal plan when appropriate

Nonmedication approaches, physical therapies, psychological strategies, and nonopioid medicines can contribute, depending on the condition. They should be selected for the actual pain problem and feasible access. A recommendation that the person cannot obtain is not a complete treatment plan.

Nonopioid does not mean risk-free. Anti-inflammatory medicines may be unsuitable with kidney, gastrointestinal, or cardiovascular issues and can interact with lithium. Sedating medicines can add impairment. Review the whole regimen before combining several products.

Opioids may require a deliberate, time-limited or ongoing plan

An addiction history does not make opioid analgesia universally forbidden, but it changes the benefit-risk discussion. Acute severe pain and specific conditions may justify opioid use with appropriate safeguards. Chronic pain prescribing requires a clear rationale and regular assessment of function and harm.

Discuss the exact treatment goal, follow-up, storage, expected duration where relevant, and what happens if pain persists. Avoid independently increasing doses or using an uncertain supply. Naloxone may be indicated, and other sedatives or alcohol require particular attention.

Coordination with opioid use disorder treatment

Surgery and emergencies need advance information

When possible, discuss procedures with the pain, surgical, anesthesia, and addiction-treatment teams in advance. Give the exact medicine, formulation, and last administration. Continuing or changing opioid use disorder treatment should be a coordinated clinical decision.

In an emergency, tell the team about naltrexone, buprenorphine, or methadone as soon as possible. Do not try to overcome naltrexone blockade with extra opioids. The team must provide appropriate analgesia while managing the specific pharmacologic and safety issues.

Plan for discharge, changes, and ongoing support

A hospital or procedure plan should include who prescribes afterward, how unused medication is handled, and when pain and recovery will be reviewed. If an opioid regimen is reduced, the pace should reflect exposure and clinical circumstances rather than an abrupt, unsupported cut.

Returning cravings, loss of control, sedation, or renewed substance use should be discussed early. Severe breathing impairment or inability to wake requires emergency response. Effective care should preserve dignity, address pain, and keep a route to addiction support open.

Set pain and function goals that reflect the actual condition

Pain management should begin with a clear assessment of the cause and the effect on daily life. Recovery history matters, but it should not replace investigation of a new injury, postoperative pain or another medical problem. Explain which activities are limited and what improvement would be meaningful. For persistent pain, useful goals may include better sleep, walking further or returning to an activity even when pain is not completely eliminated. Acute severe pain may require a different approach and a shorter review interval.

Discuss which nonmedication and medication options are feasible for the condition. Physical rehabilitation, psychological support or a nonopioid medicine may help, but availability and contraindications need consideration. A plan should not consist only of options the person cannot access. If opioids are considered, ask what benefit is expected, how harm will be monitored and how ongoing need will be assessed. The opioid treatment guide provides addiction-care background; the pain plan should still be tailored to the current clinical problem.

Coordinate analgesia with existing addiction medication

Tell the pain, surgical or emergency team about methadone, buprenorphine or naltrexone, including the formulation and when it was last given. These medicines affect opioid treatment in different ways. An opioid use disorder prescription does not by itself settle how a new painful condition will be managed. Likewise, stopping an established addiction medicine is not an automatic requirement for pain treatment. The relevant teams should coordinate the approach, especially for procedures and hospital admissions.

Naltrexone blocks opioid effects, so attempting to overcome it with extra opioid medication is dangerous. Buprenorphine and methadone also require treatment-specific planning rather than an improvised adjustment at home. Ask who will communicate with the usual prescriber and what happens after discharge. A written record can reduce confusion when several clinicians are involved. In an emergency, provide the information as soon as possible, even if advance planning was impossible. Necessary analgesia and continuity of addiction care should be considered together.

Review nonopioid medicines and combinations as carefully as opioids

A nonopioid label does not guarantee suitability. Anti-inflammatory medicines can be problematic with some kidney, stomach or cardiovascular conditions and may interact with lithium. Sedating pain treatments can add to impairment from alcohol, benzodiazepines or other psychiatric medicines. Over-the-counter combination products may contain ingredients already prescribed separately. Bring the whole list to the pharmacist or clinician so that the plan accounts for duplication, physical health and the actual products being used.

If an opioid is prescribed, discuss how it will be stored, whether naloxone is appropriate and which combinations increase risk. The naloxone guide explains its role in responding to suspected opioid overdose; it does not make every combination safe. Excessive sleepiness, slow breathing or inability to wake needs emergency action. Tell the team about cravings, escalating use or difficulty following the prescription before these become more serious. Safeguards should support treatment and communication, not make the person afraid to disclose a problem.

Make discharge and medication changes explicit

After a procedure or hospital stay, confirm which medicines continue, which stop and who will provide any further prescriptions. A temporary pain regimen can become confusing when old supplies remain at home. Ask how unused medication should be handled and when the original prescriber will receive the discharge information. The follow-up should consider pain, function, adverse effects and recovery concerns, not simply whether the prescription has run out. Persistent or unexpectedly worsening pain needs reassessment rather than repeated unsupervised dose increases.

If a longer-term opioid regimen is being reduced, the pace and support should reflect the person's exposure and clinical circumstances. Abrupt, unsupported changes can cause withdrawal and other harm. Equally, ongoing treatment should have a clear reason and regular review. Ask what the plan is if pain or cravings worsen and which service can respond. Medication changes are easier to follow when the instructions are written, the supplies match the instructions and there is a named clinician responsible for the next decision.

Making the next medication discussion useful

Bring one current list of medicines to the appointment, including the exact product, prescribed instructions, over-the-counter remedies, supplements and any medicines you take only occasionally. If the list in a clinic record is different from what you actually use, say so. Understanding the difference is more useful than trying to give an answer that sounds correct. A photograph of packaging can help clarify an unfamiliar brand or formulation.

Choose two or three priorities before the visit. These might be a persistent symptom, a side effect affecting daily life, a monitoring result or concern about continuing treatment. Describe when the problem began and whether it followed a change in medicine, illness, sleep or substance use. You do not have to diagnose the cause yourself. A clear timeline helps the clinician consider several explanations without automatically attributing everything to the psychiatric condition.

Leave with an agreed next step and a review date. If the plan changes, ask for written instructions that explain what each medicine is intended to do and whom to contact if a problem occurs. Check that the pharmacy and other prescribers have the updated plan. A useful review ends with responsibilities assigned, not simply with a recommendation to monitor the situation. Shared decisions should include your preferences, the available evidence and the practical ability to carry out the plan.

Related Medication and Treatment Guides

• Buprenorphine: treatment benefits, formulations and safety
• Naltrexone: alcohol and opioid treatment, benefits and safety
• Naloxone: opioid overdose response, nasal sprays and safety
• Private Opioid Addiction Treatment & Rehab
• Explore the Medication Guide